Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-03

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (ScieGen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved the original application for a generic fixed-dose combination of amlodipine and olmesartan medoxomil for hypertension. The product is manufactured …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)